Expert weighs in on Johnson & Johnson's one-dose COVID-19 vaccine
The third coronavirus vaccine to receive emergency-use authorization from the Food and Drug Administration is being rolled out across the U.S. Medical trials found the Johnson and Johnson vaccine is 85% effective against severe illness. John Moore, a professor of microbiology and immunology at Weill Cornell Medical College, joined CBSN to discuss.